Diabetes & Obesity Podcasts: Obesity Drugs and Co-Morbidities

November 13, 2009

Diabetes & Obesity Series


Obesity Drugs and Co-Morbidities

Subscribe to RSS feed of this series



Dr. Richard Gregg
Chief Scientific Officer
Vitae Pharmaceuticals



Dr. Gregg offers insight into the development of obesity drugs, and how co-morbidities factor into development, as well as how it impacts sites and CROs in Phase I through III trials.

Others in the Series



Diabetes Resources

Associations and Societies


Clinical Trials

Obesity Resources

Articles, Multimedia


Associations and Societies

Clinical Trials